Annual Operating Expenses
$51.00 M
+$14.88 M+41.19%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual total operating expenses is $51.00 million, with the most recent change of +$14.88 million (+41.19%) on December 31, 2023.
- During the last 3 years, DNTH annual operating expenses has risen by +$36.44 million (+250.23%).
- DNTH annual operating expenses is now at all-time high.
Performance
DNTH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$32.07 M
+$8.01 M+33.26%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly total operating expenses is $32.07 million, with the most recent change of +$8.01 million (+33.26%) on September 30, 2024.
- Over the past year, DNTH quarterly operating expenses has increased by +$15.39 million (+92.24%).
- DNTH quarterly operating expenses is now at all-time high.
Performance
DNTH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DNTH Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.2% | +92.2% |
| 3 y3 years | +250.2% | +92.2% |
| 5 y5 years | +250.2% | +92.2% |
DNTH Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +250.2% | at high | +293.1% |
| 5 y | 5-year | at high | +250.2% | at high | +293.1% |
| alltime | all time | at high | +250.2% | at high | +293.1% |
Dianthus Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.07 M(+33.3%) |
| Jun 2024 | - | $24.07 M(+28.6%) |
| Mar 2024 | - | $18.72 M(+39.6%) |
| Dec 2023 | $51.00 M | $13.41 M(-19.6%) |
| Sep 2023 | - | $16.68 M(+30.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $12.74 M(+56.2%) |
| Mar 2023 | - | $8.16 M(-31.3%) |
| Dec 2022 | $36.12 M(+148.1%) | $11.87 M(+25.9%) |
| Sep 2022 | - | $9.43 M |
| Dec 2021 | $14.56 M | - |
FAQ
- What is Dianthus Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual operating expenses year-on-year change?
- What is Dianthus Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly operating expenses year-on-year change?
What is Dianthus Therapeutics annual total operating expenses?
The current annual operating expenses of DNTH is $51.00 M
What is the all time high annual operating expenses for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual total operating expenses is $51.00 M
What is Dianthus Therapeutics annual operating expenses year-on-year change?
Over the past year, DNTH annual total operating expenses has changed by +$14.88 M (+41.19%)
What is Dianthus Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of DNTH is $32.07 M
What is the all time high quarterly operating expenses for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly total operating expenses is $32.07 M
What is Dianthus Therapeutics quarterly operating expenses year-on-year change?
Over the past year, DNTH quarterly total operating expenses has changed by +$15.39 M (+92.24%)